June 20, 2018
Dr. Bruce Carleton who developed a lab test to predict whether children with cancer are susceptible to potentially life-threatening side effects from three chemotherapy drugs is now focusing on five other medications so parents and doctors can discuss safer, personalized treatment. Bruce Carleton, director of the Pharmaceutical Outcomes Programme at B.C. Children’s Hospital, said adverse reactions linked to the five medications include bone disease, pancreatitis, anaphylaxis, nerve damage in the limbs, and inflammation of the mucous membranes, including those that may prevent patients from swallowing.
Source: CBC News
http://ow.ly/ZdFH30kwcFq
Related: Bruce Carleton and Colin Ross’s 2017 LSARP project “Go-PGX: Preventing chemotherapy side effects in Children.” https://www.genomebc.ca/projects/go-pgx-preventing-chemotherapy-side-effects-in-children/?sf_data=all&_sf_s=Carleton